- CAR T-cell therapy is a type of immunotherapy that involves genetically engineering a patient's T cells to attack cancer cells.
- T cells are a type of white blood cell that plays a key role in the immune system.
- In CAR T-cell therapy, T cells are modified in the laboratory to express an artificial receptor called a chimeric antigen receptor (CAR).
- The CAR helps the T cells recognize and bind to specific antigens on cancer cells, allowing them to kill the cancer cells.
- CAR T-cell therapy is a relatively new treatment, but it has shown promise in treating certain types of cancer, such as leukemia and lymphoma.
- In India, CAR T-cell therapy is still in its early stages, but there are a few centers that offer the treatment
- The first indigenously developed CAR T-cell therapy, NexCAR19, was approved for commercial use in October 2023.
- It is designed to treat B-cell cancers, such as leukemia and lymphoma. The therapy is now available in over 30 hospitals in more than 10 cities in India.
- The cost of CAR T-cell therapy can be high, but it is generally less expensive in India than in other countries. For example, NexCAR19 costs around ₹42 lakh, while similar therapies in the US can cost up to ₹4 crore. Please contact our experts at I care cancer clinic to discuss more regarding CART T Cell Therapy and its relevance for your cancer treatment.
For further information regarding cancer treatment
Reach our specialist at I CARE CANCER CLINIC
or Contact +91 8939 8939 95.
